These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8551789)

  • 21. Circulatory assist devices in heart failure patients.
    Hiestand BC
    Heart Fail Clin; 2009 Jan; 5(1):55-62, vi. PubMed ID: 19026386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombosis of the ascending aorta during mechanical circulatory support in a patient with cardiogenic shock.
    Leontiadis E; Koertke H; Bairaktaris A; Koerfer R
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):510-1. PubMed ID: 20656800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of an extraaortic counterpulsation device versus intraaortic balloon pumping in severe cardiac failure.
    Zelano JA; Ko W; Lazzaro R; Lazenby WD; Topaz S; Kolff WJ; Isom OW; Krieger KH
    ASAIO Trans; 1991; 37(3):M342-4. PubMed ID: 1751178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock.
    Pavlidis AN; Redwood SR; Clapp BR
    J Invasive Cardiol; 2014 May; 26(5):E50-1. PubMed ID: 24791724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of the high volume counterpulsation technique at very low levels of aortic pressure.
    Charitos CE; Nanas JN; Kontoyiannis DA; Nanas SN; Stamatopoulos GZ; Rapti AC; Stamatelopoulos SF; Moulopoulos SD
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):625-32. PubMed ID: 9833723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous left ventricular support in cardiogenic shock and severe aortic regurgitation.
    Pham DT; Al-Quthami A; Kapur NK
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):399-401. PubMed ID: 22639446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock.
    Kapur NK; Davila CD; Jumean MF
    Interv Cardiol Clin; 2017 Jul; 6(3):481-485. PubMed ID: 28600099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.
    Mandawat A; Rao SV
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28500136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of an implantable left ventricular assist device in a patient with cardiogenic shock following acute myocardial infarction.
    Chua TP; Pepper JR; Fox KM
    Int J Cardiol; 1998 Sep; 66(1):55-8. PubMed ID: 9781788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.
    Brugts JJ; Caliskan K
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):145-53. PubMed ID: 24417434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of cardiogenic shock and medically refractory left ventricular failure in acute myocardial infarction and acute myocarditis by intraaortic balloon counterpulsation].
    Yoshikawa J; Yanagihara K; Asaka T; Kato H; Okumachi F; Yoshida K; Syomura T
    J Cardiogr Suppl; 1984; (3):93-7. PubMed ID: 6536694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and early testing of a simple subcutaneous counterpulsation device.
    Koenig SC; Spence PA; Pantalos GM; Dowling RD; Litwak KN
    ASAIO J; 2006; 52(4):362-7. PubMed ID: 16883113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quest for permanent ventricular assistance: the role of aortic counterpulsation.
    Jeevanandam V
    ASAIO J; 2004; 50(6):xxxvii-xlii. PubMed ID: 15672778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circulatory assist device in counterpulsation].
    Leirner AA; Marques E; Ribeiro MP; Lage SG; Jatene AD
    Arq Bras Cardiol; 1990 Aug; 55(2):99-103. PubMed ID: 2073183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-centre experience with the Thoratec paracorporeal ventricular assist device for patients with primary cardiac failure.
    Kirsch M; Vermes E; Damy T; Nakashima K; Sénéchal M; Boval B; Drouet L; Loisance D
    Arch Cardiovasc Dis; 2009; 102(6-7):509-18. PubMed ID: 19664570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of cardiogenic shock with exclusion of inotropic drugs].
    Lançon JP; Volot F; Beaufils C; Caillard B
    Agressologie; 1991; 32(1):35-6. PubMed ID: 2063979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salutary Effects of the PULVAD, a Novel Implantable Counterpulsation Assist Device, on Cardiac Mechanoenergetics.
    Kontogiannis C; Aravantinos D; Nanas I; Kapelios CJ; Marinakis S; Vakrou S; Sarchosi S; Perrea DN; Mason JW; Nanas JN; Malliaras K
    ASAIO J; 2019 Jul; 65(5):473-480. PubMed ID: 29877888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicted hemodynamic benefits of counterpulsation therapy using a superficial surgical approach.
    Giridharan GA; Pantalos GM; Litwak KN; Spence PA; Koenig SC
    ASAIO J; 2006; 52(1):39-46. PubMed ID: 16436889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portable enhanced external counterpulsation for acute coronary syndrome and cardiogenic shock: a pilot study.
    Cohen J; Grossman W; Michaels AD
    Clin Cardiol; 2007 May; 30(5):223-8. PubMed ID: 17492675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.